Drug Utilization Profile among Outpatients with Dyspepsia at Tuan Rondahaim Regional General Hospital, Pamatang Raya, 2025
Keywords:
Drug use profile, DyspepsiaAbstract
Changes in diet and lifestyle are one of the causes of disturbances in the digestive tract. Dyspepsia is a digestive disorder that suffers a lot and is the most common Dyspepsia can be influenced by several factors, namely increased gastric acid secretion, dietary factors, environmental factors, and psychological factors such as stress. Retrospective qualitative descriptive research with cross sectional and the sampling technique is Purposive Sampling. Samples from the study were obtained from prescription outpatient adult dyspepsia patients aged 18- 65 years at the RSUD Tuan Rondahaim Pamatang Raya. Most sufferers of dyspepsia were female, namely 56 (56%), age range 56–65 the number of patients was 65 (65%). The drug class that is widely used is PPI with the type of drug omeprazole 20 mg in 42 patients (30%), with a frequency of 2 x 1. The most widely used dosage form wa omperazole capsule preparations, namely 42 (30%), the oral route of administration. Accompanying drugs in patients with dyspepsia, namely from the multivitamin group, namely vitamins B complex, the number of uses was 14 (22,58%) and the use of a single dyspepsia drug combination therapy is omeprazole 31 (31%), combination 2 dyspepsia drug that a lot of cytoprotective with PPI and a combination of 3 dyspepsia drug namely PPI, Cytoprotective, Prokinetic.
References
Abdullah, M., & Gunawan, J. (2012). Functional dyspepsia. Division of Gastroenterology, Department of Internal Medicine, Faculty of Medicine, Universitas Indonesia, Jakarta.
Aru, W. S. (2019). Textbook of Internal Medicine. Jakarta: Internal Publishing.
Beniatriska, R. D. (2014). The relationship between stress and the incidence of dyspepsia among undergraduate students of the Faculty of Medicine, Universitas Muhammadiyah Surakarta.
Dewi, A. (2017). The relationship between stress levels and characteristics of dyspepsia syndrome in students of the 2016 cohort, Faculty of Medicine, Universitas Hasanuddin.
Djojoningrat, D. (2014). Dyspepsia function and ulcer. In A. Sudoyo et al. (Eds.), Textbook of Internal Medicine (6th ed.). Jakarta: Internal Publishing.
Djojoningrat, D. (2019). Dyspepsia disease. In Textbook of Internal Medicine. Jakarta: Internal Publishing.
Fithriyana, R. (2018). Risk factors for dyspepsia disease among patients in the working area of Puskesmas Bangkinang Kota (2, 43–54).
Gunawan, J. (2017). Digestive system diseases (pp. 17–19). Yogyakarta: Kanisius.
Irianto, K. (2015). Digestive diseases. Bandung: Alfabeta.
Katzung, B. G., Masters, S. B., & Trevor, A. J. (2014). Basic and clinical pharmacology. Jakarta: EGC Medical Book Publisher.
Nasif, H., Yulme, M., & Muchtar, H. (2013). Analysis of drug utilization patterns in dyspepsia patients at Dr. Achmad Mochtar Hospital, Bukittinggi. Pharmacon, 18(1), 17–27.
Ortiz, A. C., Alvarez, A., Gomez, Y., Sarosiek, M., & McCallum, R. W. (2015). Cardiovascular safety profile and clinical experience with high-dose domperidone therapy for nausea and vomiting. American Journal of Therapeutics, 22(2), 112–118.
Panggabean, M. S. (2017). Antacids and proton pump inhibitors. Hasil Tinjauan Pustaka, 5(1), 10–11.
Purnamasari, L. (2019). Risk factors, classification, and therapy of dyspepsia syndrome. Continuing Medical Education, 4(12), 870–873.
Reshetnikov, O. V. (2018). Prevalence of dyspepsia and irritable bowel syndrome among adolescent of Novosibirsk. International Medicine Russia, 1(1), 33–39.
Simadibrata, M. (2019). 2017 Current issues of gastroenterology. Acta Medica Indonesiana, 49(3), 270–278.
Suliwati, F. S., & Sardely, J. W. (2013). Relationship between eating patterns and dyspepsia incidence. Surya Medika, 3(1), 15–21.
Wu, J. C., Wong, C. H., & Lee, Y. C. (2016). Comparison of effectiveness of omeprazole and teprenone in treatment of chronic superficial gastritis. Chinese Medical Journal, 129(7), 805–810..
